Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
imara
2
×
indiana blog main
indiana top stories
life sciences
national
2
×
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
sanofi
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
acc
acquisition
activist investor
aducanumab
akouos
allergan
alnylam pharmaceuticals
alzheimer's failure
amag pharmaceuticals
american college of cardiology
amunix
What
bio
help
roundup
acquisitions
adu
announced
approved
beats
bids
biogen
ceo
collabs
complicated
covid
daniel
deal
depression
dire
drug
gilead
gilead’s
good
group
heart
introduce
ipo
medical
medicines
month
need
news
o’day
people
plans
postpartum
relief
sage
sciences
transformative
week
Language
unset
Current search:
imara
×
national
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
5 years ago
Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More
